← All trials
NCT01501773
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Oct 1, 2011
- Completion date
- Oct 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Manipal Acunova Ltd.Lead sponsor
- Sanjay Gandhi Postgraduate Institute of Medical SciencesOverall official - principal investigator
- Department of DefenseOverall official - principal investigator
- Postgraduate Institute of Medical Education and ResearchOverall official - principal investigator
- India ArmyOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- Government of IndiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.